Schott Evelyn, Schaller Katrin, Mons Ute, Ouédraogo Nobila
Stabsstelle Krebsprävention, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Deutschland; Medizinische Fakultät Heidelberg, Universität Heidelberg, Heidelberg, Deutschland.
Stabsstelle Krebsprävention, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Deutschland.
Z Evid Fortbild Qual Gesundhwes. 2022 May;170:29-37. doi: 10.1016/j.zefq.2022.02.002. Epub 2022 Apr 28.
In Germany, the prevalence of infections with the human papilloma virus (HPV) among women and men is high. High-risk HPV types can lead to certain types of cancer (e. g., cervical cancer). Vaccination against HPV infections associated with cancer and genital warts was introduced in Germany in 2007. Currently, HPV vaccination is recommended for girls and boys by the German Standing Committee on Vaccination. The vaccination rate, however, remains rather low, with rates below 50% in 15-year-old girls and of about 5% in 15-year-old boys in 2019. This suggests that new approaches are urgently needed to increase HPV vaccination coverage in Germany in the coming years.
This qualitative study aimed at identifying opportunities and challenges related to the application and implementation of different approaches designed to increase HPV vaccination uptake among male and female adolescents in Germany according to expert views.
From April to July 2020, 43 experts from the field of HPV vaccination in Germany were interviewed using a semi-standardized interview guide. The audiotaped interviews were transcribed and analyzed using qualitative content analysis by Udo Kuckartz.
According to the experts interviewed the following would be the most promising approaches to increase HPV vaccination rates in Germany: educational measures, school vaccination programs, increasing participation in the adolescent health check-up "J1", reminder and recall systems. The most reasonable solution would be to pursue several approaches simultaneously. According to the experts, more political support with implementing strategies and reducing bureaucratic obstacles as well as an increase in cooperation between relevant stakeholders is required to achieve the effective implementation of these strategies.
在德国,人乳头瘤病毒(HPV)在女性和男性中的感染率很高。高危型HPV可导致某些类型的癌症(如宫颈癌)。2007年德国引入了针对与癌症和尖锐湿疣相关的HPV感染的疫苗接种。目前,德国疫苗接种常设委员会建议女孩和男孩接种HPV疫苗。然而,疫苗接种率仍然很低,2019年15岁女孩的接种率低于50%,15岁男孩的接种率约为5%。这表明未来几年迫切需要新的方法来提高德国HPV疫苗的接种覆盖率。
本定性研究旨在根据专家意见,确定与德国不同方法的应用和实施相关的机会和挑战,这些方法旨在提高德国青少年男女的HPV疫苗接种率。
2020年4月至7月,使用半标准化访谈指南对德国HPV疫苗接种领域的43名专家进行了访谈。对录音访谈进行转录,并由乌多·库卡茨使用定性内容分析法进行分析。
根据受访专家的意见,以下是提高德国HPV疫苗接种率最有前景的方法:教育措施、学校疫苗接种计划、增加参与青少年健康检查“J1”、提醒和召回系统。最合理的解决方案是同时采用多种方法。专家们认为,需要更多的政治支持来实施战略和减少官僚障碍,以及加强相关利益攸关方之间的合作,以有效实施这些战略。